Cargando…

Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Gallo, Antonio, Capuano, Rocco, Donnarumma, Giovanna, Bisecco, Alvino, Grimaldi, Elena, Conte, Miriana, D'Ambrosio, Alessandro, Galdiero, Massimiliano, Tedeschi, Gioacchino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498604/ http://dx.doi.org/10.1016/j.jns.2021.117795

Ejemplares similares

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
por: Capuano, Rocco, et al.
Publicado: (2022)

Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
por: Capuano, Rocco, et al.
Publicado: (2022)

Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
por: Capuano, Rocco, et al.
Publicado: (2021)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Persistent aura-like visual phenomenon as the unique manifestation of COVID-19 post-infectious white matter lesion: A case report
por: Matrone, Federica, et al.
Publicado: (2021)

Psychological consequences of COVID-19 pandemic on people with multiple sclerosis: A meta-analytic study
por: Altieri, Manuela, et al.
Publicado: (2021)

The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis
por: Altieri, Manuela, et al.
Publicado: (2022)

Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population
por: Capuano, Rocco, et al.
Publicado: (2021)

Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?
por: Capuano, Rocco, et al.
Publicado: (2020)

Functional Plasticity of the Visual System in Multiple Sclerosis
por: Gallo, Antonio, et al.
Publicado: (2015)

Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study
por: Bisecco, Alvino, et al.
Publicado: (2020)

Stimulated single-fiber electromyography (sSFEMG) in Lambert-Eaton syndrome
por: Todisco, Vincenzo, et al.
Publicado: (2018)

Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study
por: Lanzillo, Roberta, et al.
Publicado: (2022)

Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set
por: Marzi, Chiara, et al.
Publicado: (2022)

Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative
por: De Rosa, Alessandro Pasquale, et al.
Publicado: (2022)

Correction to: Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative
por: De Rosa, Alessandro Pasquale, et al.
Publicado: (2023)

Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
por: Smets, I., et al.
Publicado: (2021)

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
por: Russo, Antonio, et al.
Publicado: (2020)

Blunted humoral response after mRNA vaccine in patients with haematological malignancies
por: Kamboj, Mini
Publicado: (2021)

Neurophysiological and behavioural correlates of ocrelizumab therapy on manual dexterity in patients with primary progressive multiple sclerosis
por: Dubbioso, Raffaele, et al.
Publicado: (2022)

Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
por: Katz, J.D., et al.
Publicado: (2022)

Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis
por: Femiano, Cinzia, et al.
Publicado: (2018)

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
por: Emery, Paul, et al.
Publicado: (2014)

Ocrelizumab-Induced Severe Colitis
por: Lee, Hsing Hwa, et al.
Publicado: (2020)

Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
por: van Kempen, Z.L.E., et al.
Publicado: (2022)

Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study
por: Capasso, Nicola, et al.
Publicado: (2022)

Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia
por: Conte, William L
Publicado: (2020)

Blunt traumatic isolated duodenal perforation treated by multimodal endoscopic approach
por: Donnarumma, Durante, et al.
Publicado: (2023)

Ocrelizumab: A Review in Multiple Sclerosis
por: Lamb, Yvette N.
Publicado: (2022)

Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab
por: Landi, Doriana, et al.
Publicado: (2022)

Ocrelizumab zur Behandlung der Multiplen Sklerose
por: Graf, Jonas, et al.
Publicado: (2020)

Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020)

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
por: Cellerino, Maria, et al.
Publicado: (2021)

Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study
por: Conte, William L.
Publicado: (2021)

In Vitro Evaluation of the Most Active Probiotic Strains Able to Improve the Intestinal Barrier Functions and to Prevent Inflammatory Diseases of the Gastrointestinal System
por: Fusco, Alessandra, et al.
Publicado: (2023)

Evaluation of Different Activity of Lactobacillus spp. against Two Proteus mirabilis Isolated Clinical Strains in Different Anatomical Sites In Vitro: An Explorative Study to Improve the Therapeutic Approach
por: Fusco, Alessandra, et al.
Publicado: (2023)

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment
por: Prezioso, Carla, et al.
Publicado: (2021)

Ocrelizumab: a new milestone in multiple sclerosis therapy
por: Mulero, Patricia, et al.
Publicado: (2018)

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
por: Turner, Benjamin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j3pdef5hanagu3mbia5bgsbqdh